IL184843A0 - Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof - Google Patents

Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof

Info

Publication number
IL184843A0
IL184843A0 IL184843A IL18484307A IL184843A0 IL 184843 A0 IL184843 A0 IL 184843A0 IL 184843 A IL184843 A IL 184843A IL 18484307 A IL18484307 A IL 18484307A IL 184843 A0 IL184843 A0 IL 184843A0
Authority
IL
Israel
Prior art keywords
genes encoding
susceptibility genes
neurotransmitter transporter
autism susceptibility
human autism
Prior art date
Application number
IL184843A
Other languages
English (en)
Original Assignee
Integragen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integragen Sa filed Critical Integragen Sa
Publication of IL184843A0 publication Critical patent/IL184843A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Psychology (AREA)
  • Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL184843A 2005-02-28 2007-07-26 Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof IL184843A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65637405P 2005-02-28 2005-02-28
PCT/IB2006/001100 WO2006090288A2 (en) 2005-02-28 2006-02-27 Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof

Publications (1)

Publication Number Publication Date
IL184843A0 true IL184843A0 (en) 2007-12-03

Family

ID=36607270

Family Applications (1)

Application Number Title Priority Date Filing Date
IL184843A IL184843A0 (en) 2005-02-28 2007-07-26 Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof

Country Status (7)

Country Link
US (1) US20080213765A1 (https=)
EP (1) EP1859060A2 (https=)
JP (1) JP2008532499A (https=)
AU (1) AU2006217543A1 (https=)
CA (1) CA2599327A1 (https=)
IL (1) IL184843A0 (https=)
WO (1) WO2006090288A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101935673B (zh) * 2009-07-03 2013-08-21 中国科学院上海生命科学研究院 用于抑制小鼠γ-氨基丁酸转运蛋白亚型1的siRNA
EP4055174A4 (en) 2019-11-08 2024-01-03 The Board Of Regents Of The University Of Texas System TRANSGENIC CASSETTES, AAV VECTORS AND AAV VECTORS FOR EXPRESSING HUMAN CODON-OPTIMIZED SLCA1
WO2021113773A2 (en) * 2019-12-04 2021-06-10 Pai Athma A Identifying non-productive splice sites
IL301255A (en) * 2020-10-09 2023-05-01 UCB Biopharma SRL Nucleic acid structures, viral vectors and viral particles
CA3207224A1 (en) * 2021-02-02 2022-08-11 Bryan GORE Artificial expression constructs for modulating gene expression in gabaergic neurons and astrocytes
WO2023022269A1 (ko) * 2021-08-20 2023-02-23 단국대학교 천안캠퍼스 산학협력단 주의력결핍 과잉행동장애의 예방 또는 치료용 약학적 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19911130A1 (de) * 1999-03-12 2000-09-21 Hager Joerg Verfahren zur Identifikation chromosomaler Regionen und Gene
EP1554403A1 (en) * 2002-10-10 2005-07-20 K.U. Leuven Research and Development Autism gene

Also Published As

Publication number Publication date
EP1859060A2 (en) 2007-11-28
AU2006217543A1 (en) 2006-08-31
US20080213765A1 (en) 2008-09-04
WO2006090288A2 (en) 2006-08-31
WO2006090288A3 (en) 2006-11-02
JP2008532499A (ja) 2008-08-21
CA2599327A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
IL247617A0 (en) Peptide nanoparticles and their uses
GB0702020D0 (en) Peptides and their use
EP1902408A4 (en) ACTIVE DISPLAY USING AN INCORPORATED INTERACTION CODE (EIC)
GB2455258B (en) Rendering and encoding glyphs
EP1976864A4 (en) NEW PEPTIDE AND ITS USE
IL185308A0 (en) Replikin peptides and uses thereof
EP1896986A4 (en) PROCESS TECHNICAL GRAPHIC ARCHITECTURES AND METHOD
EP2029448A4 (en) TRANSPORT APPARATUS
GB0702021D0 (en) Peptides and their use
IL189252A0 (en) Dihydroxyanthraquinones and their use
IL184843A0 (en) Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof
GB0702022D0 (en) Peptides and their use
IL195525A0 (en) Replikin peptides and uses thereof
IL184641A0 (en) Human autism susceptibility gene encoding a kinase and uses thereof
GB0613675D0 (en) Image encoding and decoding
EP1844068A4 (en) MOLECULES AND THEIR CHIMERIC MOLECULES
EP1918297A4 (en) PEPTIDE INDUCING NEURONAL DIFFERENTIATION AND APPLYING THEREOF
GB0604187D0 (en) Peptide and uses thereof
GB0823550D0 (en) Peptide tag and uses thereof
GB0617564D0 (en) Peptides and methods
IL192800A0 (en) Fgf2-binding peptides and uses thereof
ZA200801664B (en) Amino acid and its uses
GB0701921D0 (en) Encoding and decoding methods
GB0515216D0 (en) Beach personnel transporter
GB0623978D0 (en) Bar code and RFID reading device